NASDAQ : GRAL
GRAIL, Inc. — Key statistics
Healthcare · Diagnostics & Research · United States
Last price 143.43 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 6.41B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 6.04B |
| Enterprise Value | 5.27B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 4, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 44.67M |
| Shares Outstanding | 44.67M |
| Shares Change (YoY) | +18.48% |
| Shares Change (QoQ) | +6.08% |
| Owned by Insiders (%) | 1.86% |
| Owned by Institutions (%) | 68.60% |
| Float | 34.34M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 38.71 |
| Forward PS | 31.93 |
| PB Ratio | 2.52 |
| P/TBV Ratio | 8.40 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 34.05 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 10.95 |
| Quick Ratio | 10.55 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -16.12% |
| Return on Assets (ROA) | -12.03% |
| Return on Invested Capital (ROIC) | -13.32% |
| Return on Capital Employed (ROCE) | -19.34% |
| Weighted Average Cost of Capital (WACC) | 19.58% |
| Revenue Per Employee | $181,608 |
| Profits Per Employee | -$430,315 |
| Employee Count | 910 |
| Asset Turnover | 0.06 |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | -137.88M |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 2.84 |
| 52-Week Price Change | +46.99% |
| 50-Day Moving Average | 112.52 |
| 200-Day Moving Average | 78.19 |
| Relative Strength Index (RSI) | 52.12 |
| Average Volume (20 Days) | 941,705 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 8.17M |
| Short Previous Month | 8.01M |
| Short % of Shares Out | 18.30% |
| Short % of Float | 23.80% |
| Short Ratio (days to cover) | 5.44 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 165.26M |
| Gross Profit | 82.15M |
| Operating Income | -533.86M |
| Pretax Income | -529.47M |
| Net Income | -391.59M |
| EBITDA | -378.49M |
| EBIT | -533.86M |
| Loss Per Share | -$9.75 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 861.61M |
| Total Debt | 91.31M |
| Net Cash | 770.30M |
| Net Cash Per Share | $17.25 |
| Equity (Book Value) | 2.54B |
| Book Value Per Share | 56.93 |
| Working Capital | 831.18M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -294.75M |
| Capital Expenditures | -1.41M |
| Depreciation & Amortization | 155.37M |
| Net Borrowing | n/a |
| Free Cash Flow | -296.16M |
| FCF Per Share | -$6.63 |
Margins
| Measure | Value |
|---|
| Gross Margin | 49.71% |
| Operating Margin | -323.04% |
| Pretax Margin | -320.38% |
| Profit Margin | -236.95% |
| EBITDA Margin | -229.02% |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -18.48% |
| Shareholder Yield | -18.48% |
| Earnings Yield | -7.21% |
| FCF Yield | -4.63% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $132.56 |
| Price Target Difference | -2.02% |
| Analyst Consensus | Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (3Y) | 24.88% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -0.27 |
| Piotroski F-Score | 4 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |